Dietary supplements and osteoarthritisNovember 21, 2019A multimodal approach to the management of OA has been recommended to target different pain receptors and attempt to control inflammation within the joints.
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
Elanco guide helps owners spot OAOctober 10, 2019Veterinarians are now better equipped to educate clients on canine osteoarthritis (OA), thanks to Elanco Animal Health.
Osteoarthritis in pets on the rise alongside obesity epidemicJune 25, 2019The prevalence of osteoarthritis (OA) in pets has skyrocketed in the past decade, with the condition seeing a 66 percent increase in dogs and a 150 percent increase in cats.
Penn Vet to study hemp-based canine supplementMay 28, 2019A trial at the University of Pennsylvania School of Veterinary Medicine (Penn Vet) will be looking at the effectiveness of a hemp-based supplement to relieve symptoms of canine joint immobility. Approximately 60 dogs who are suffering from inflammation secondary to osteoarthritis will be split into three groups. One group will receive Mobility, which was developed by Dixie Brands' subsidiary Therabis. The second group will receive CBD, and the last group will receive a placebo. The dogs will then be studied to see which group achieves a better outcome. "We are honored to have a Therabis product selected by the world-renowned experts at Penn Vet for their first major study of the effects of natural hemp oil to reduce joint pain in dogs," says Therabis cofounder, Stephen M. Katz, DVM. "Our experience in my clinic has shown cannabidiol (CBD) is an effective treatment in reducing inflammatory response. We have a passion for improving dogs' quality of life, and we look forward to learning all we can about therapeutic methods to achieve this." Physical tests will be used to measure the effectiveness of the products, mostly focusing on the front leg joints. Results are expected in approximately 12 months.
Joint inflammation: Corticosteroids and other management strategiesMay 23, 2019Working horses are commonly diagnosed with, and are treated for, acute or chronic joint inflammation. For many decades, intra-articular (IA) injections of corticosteroids have been used to treat these conditions. However, considering how popular these injections are and the fact other treatment options exist, there is little consensus on questions regarding the "best" corticosteroid, how often such injections can be used, and how ultimately deleterious they are to joint cartilage. Treatment rationale Corticosteroid injections are one of the most commonly prescribed treatments for joint pain and inflammation resulting from osteoarthritis. Arthritis, of course, is inflammation of a joint. Uncontrolled, osteoarthritis is thought to lead to chronic changes in the cartilage and underlying subchondral bone. The cycle of inflammation, cartilage and bone damage, pain, and further cartilage and/or bone damage from ongoing inflammation can result in horses that are unable to perform for their intended use, or worse, are chronically lame and in pain. Corticosteroids are injected into joints in an effort to decrease inflammation. While the drugs are not directly pain-relieving, reducing joint inflammation can help interrupt the joint-inflammation cycle, thereby reducing pain. By decreasing pain and inflammation, horses are able to move more normally. Commonly used corticosteroids Three …
Banfield and NAVC release report on osteoarthrosis in obese animalsJanuary 24, 2019A new report says 51 percent of dogs and 41 percent of cats diagnosed with osteoarthritis (OA) in 2017 were considered overweight or obese.
Use a joint approach to osteoarthritisJuly 9, 2018As they age, approximately 20 percent of dogs experience osteoarthritis, a condition exacerbated by excess weight as well as by stress on joints from working or performance activities. Breeds such as golden and Labrador retrievers are overrepresented, but degenerative joint disease isn’t limited to highly active dogs or even to old dogs.
Companion Animal Health offers live-stream OA management courseMay 17, 2018Companion Animal Health has introduced a live-stream option for the company's Management of Geriatric Pets with Mobility Issues for the General Practitioner course. The course is designed to give general veterinary practices access to the tools required to meet the need for expanded osteoarthritis treatment options in companion animals, according to Newark, Del.-based Companion Animal Health. Attendees will earn 11 continuing education credits while learning multimodal approaches for successfully managing the geriatric, arthritic, and obese dog/cat. Course topics include: Photobiomodulation (laser therapy) for osteoarthritis Nutraceutical use for the geriatric, arthritic pet Pharmacologic management of osteoarthritis Business and marketing strategies Enrollment is now open. Veterinary professionals interested in attending this course can get more information on dates and pricing here.
MAF study finds tramadol ineffective against osteoarthritis in dogsMay 9, 2018 A report funded by the Morris Animal Foundation (MAF) out of the University of Georgia has found tramadol to be ineffective in alleviating signs of pain associated with osteoarthritis in dogs. "The data shows conclusively that tramadol is not an effective drug in treating the pain associated with arthritis in the dog, despite its common recommendation," said Steven Budsberg, DVM, BS, MS, DACVS, professor of surgery/director of clinical research at the University of Georgia College of Veterinary Medicine. "This use of tramadol is a classic example of failing to acknowledge and control for bias when evaluating a potential treatment." The reported data was collected by Dr. Budsberg and his research team via a randomized, blinded, placebo, and positive-controlled crossover study. The group compared tramadol against both placebo and nonsteroidal anti-inflammatory drugs, with dogs afflicted with osteoarthritis of the elbow or knee assigned to receive each of three treatments in a random order and each treatment arm lasting for 10 days. Improvement was measured using a variety of tests to evaluate the patient's gait and pain. The results showed no improvement when tramadol was administered compared to either baseline or placebo. "This study reinforces the need to carefully and …
CE explores expanded treatment options for improving mobility in geriatric petsSeptember 19, 2017Companion Animal Health has opened enrollment for an educational course that the company said is "designed specifically to give general veterinary practices access to the tools required to meet the need for expanded osteoarthritis treatment options in companion animals" and "will equip practices with the practical knowledge of the best multimodal approaches for successfully managing the geriatric, arthritic, and obese dog and/or cat." Attendees will earn 11 continuing education credits, with the option of adding a regenerative medicine wet-lab to advance their expertise (for an additional four CE credits). A panel of speakers will educate attendees on the following topics: Nutritional Management for the Geriatric Dog or Cat Photobiomodulation (Laser Therapy) for OA Nutriceutical Use for the Geriatric, Arthritic Pet Pharmacologic Management of OA Business & Marketing Strategies "We took a look at what courses were being offered in our profession currently, and there weren't really any that combined more than one or two OA treatment options," said Lisa Miller, DVM, CCRT, CVA. "This disease responds best to a multimodal approach, so we designed a course to accommodate that need." Veterinary professionals interested in attending this course can find more information on dates, …
